Determination of bupropion using liquid chromatography with fluorescence detection in pharmaceutical preparations, human plasma and human urine

Journal of Chromatographic Science

Volumn 50, Issue 5, 2012, Pages 433-439

  Ulu, Sevgi Tatar ^a   Tuncel, Muzaffer ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ANADOLU UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

4 CHLORO 7 NITROBENZOFURAZAN; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; DRUG;

ARTICLE; BLOOD; CHEMISTRY; EVALUATION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; METHODOLOGY; SPECTROFLUOROMETRY; URINE;

4-CHLORO-7-NITROBENZOFURAZAN; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORESCENCE; HUMANS; LIMIT OF DETECTION; PHARMACEUTICAL PREPARATIONS; SPECTROMETRY, FLUORESCENCE;

EID: 84862292326     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/bms020     Document Type: Article

References (29)

1. Holm, K.J., Spencer, C.M.; Bupropion: A review of its use in the management of smoking cessation; Drugs, (2000); 59: 1007-1024.
2. Stewart, J.J., Berkel, H.J., Parish, R.C., Simar, M.R., Syed, A.J., Bocchini, A. et al.; Single-dose pharmacokinetics of bupropion in adolescents: Effects of smoking status and gender; Journal of Clinical Pharmacology, (2001); 41: 770-778.
3. Dhillon, S., Yang, L.P., Curran, M.P.; Bupropion: A review of its use in the management of major depressive disorder; Drugs, (2008); 68: 653-89.
4. Patel, J.K., Rathod, I.S.; Derivative spectrophotometric method for simultaneous estimation of nicotine and bupropion hydrochloride in synthetic mixture; Journal of Pharmaceutical Research, (2009); 9: 1370-1372.
5. Yeniceli, D., Dogrukol-Ak, D.A.; Validated thin-layer chromatograph-ic method for the determination of bupropion hydrochloride in pharmaceutical dosage form; Journal of Planar Chromatography-Modern TLC, (2010); 23: 212-218.
6. Yeniceli, D., Dogrukol-Ak, D.; Retention behaviour of bupropion hydrochloride in reversed-phase ion-pair LC and validated determination of the drug in pharmaceuticals; Chromatographia, (2010); 71: 79-84.
7. Yeniceli, D., Dogrukol-Ak, D.; An LC method for the determination of bupropion and its main metabolite, hydroxybupropion in human plasma; Chromatographia, (2009); 70: 1703-1708.
8. Jennison, T.A., Brown, P., Crossett, J., Urry, F.M.; A high-performance liquid chromatographic method for quantitating bupropion in human plasma or serum; Journal of Analytical Toxicology, (1995); 19: 69-72.
9. Zhang, D., Yuan, B., Qiao, M., Li, F.; HPLC determination and pharmacokinetics of sustained-release bupropion tablets in dogs; Journal of Pharmaceutical and Biomedical Analysis, (2003); 33: 287-293.
10. Loboz, K.K., Gross, A.S., Ray, J., McLachlan, A.J.; HPLC assay for bu-propion and its major metabolites in human plasma; Journal of Chromatography B, (2005); 823: 115-121.
11. Cooper, T.B., Suckow, R.F., Glassman, A.; Determination of bupro-pion and its major basic metabolites in plasma by liquid chromatog-raphy with dual-wavelength ultraviolet detection; Journal of Pharmaceutical Science, (1984); 73: 1104-1107.
12. Khalil, I.A.; Rapid determination of bupropion in human plasma by high performance liquid chromatography; Journal of Liquid Chromatography and Related Technologies, (1989); 12: 645-655.
13. Sane, R.T., Francis, M., Khedkar, S.; Gas chromatographic determination of bupropion hydrochloride from its pharmaceutical formulations; Indian Drugs, (2003); 40: 231-233.
14. Rohrig, T.P., Ray, N.G.; Tissue distribution of bupropion in a fatal overdose; Journal of Analytical Toxicology, (1992); 16: 343-345.
15. Borges, V., Yang, E., Dunn, J., Henion, J.; High-throughput liquid chromatography-tandem mass spectrometry determination of bupropion and its metabolites in human, mouse and rat plasma using a monolithic column; Journal of Chromatography B, (2004); 804: 277-287.
16. Coles, R., Kharasch, E.D.; Stereoselective analysis of bupropion and hydroxybupropion in human plasma and urine by LC/MS/MS; Journal of Chromatography B, (2007); 857: 67-75.
17. Castro-Puyana, M., Angeles, G.M., Luisa, M.M.; Enantiomeric separation of bupropion enantiomers by electrokinetic chromatography: Quantitative analysis in pharmaceutical formulations; Journal of Chromatography B, (2008); 875: 260-265.
18. ICH; Validation of analytical procedures: Methodology. ICH harmonised tripartite guideline, (1996).
19. Rocci, M.L., Jr., Devanarayan, V., Haughey, D.B., Jardieu, P.; Confirmatory reanalysis of incurred bioanalytical samples; AAPS Journal, (2007); 9: E336-343.
20. Pesez, M., Bartos, J.; Colorimetric and fluorimetric analysis of organic compounds and drugs, Marcel Dekker, New York, NY, (1974), pp. 170-171.
21. Abdel-Wadood, H.M., Mohamed, N.A., Mahmoud, A.M.; Validated spectrofluorometric methods for determination of amlodipine besylate in tablets; Spectrochimica Acta, Part B, (2008); 70: 564-570.
22. Ulu, T.S.; Highly sensitive spectrofluorimetric determination of ephedrine hydrochloride in pharmaceutical preparations; Journal of AOAC International, (2006); 89: 1263-1267.
23. Ulu, T.S.; Determination of tianeptine in human plasma using high-performance liquid chromatography with fluorescence detection; Journal of Chromatography B, (2006); 834: 62-67.
24. Ulu, T.S.; Development of an HPLC method for the determination of mexiletine in human plasma and urine by solid-phase extraction; Talanta, (2007); 72: 1172-1177.
25. Bahrami, G., Mohammadi, B.; Sensitive microanalysis of gabapentin by high-performance liquid chromatography in human serum using pre-column derivatization with 4-chloro-7-nitrobenzofurazan: Application to a bioequivalence study; Journal of Chromatography B, (2006); 837: 24-28.
26. Bahrami, G., Mirzaeei, S.; Simple and rapid HPLC method for determination of amlodipine in human serum with fluorescence detection and its use in pharmacokinetic studies; Journal of Pharmaceutical and Biomedical Analysis, (2004); 36: 163-168.
27. Bahrami, G., Mohammadi, B.; Rapid and sensitive bioanalytical method for measurement of fluvoxamine in human serum using 4-chloro-7-nitrobenzofurazan as pre-column derivatization agent: Application to a human pharmacokinetic study; Journal of Chromatography B, (2007); 857: 322-332.
28. Imai, K., Uzu, S., Toyooka, T.; Fluorogenic reagents having benzofur-azan structure in liquid chromatography; Journal of Pharmaceutical and Biomedical Analysis, (1989); 7: 1395-1403.
29. USP XXXI, The United States Pharmacopeia, 31st ed., Vol. 2, US Pharmacopeial Convention, Rockville, MD, (2008), pp. 1572-1574.